Evidence map›Paper›PMID 42819242›Full record

ArticleFrontiers in sleep2026

Responsiveness of ThymoDream

C S Harshith, Thomas V Jestin, Das S Syam, Prabhakaran Prathibha, Nithyanandam Allimuthu, N Abhirami, A Radhika, I M Krishnakumar, Janeesh Plakkal Ayyappan

Abstract read
In one paragraph

Article in Frontiers in sleep, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

C S HarshithBGS Global Institute of Medical Sciences, Bangalore, Karnataka, India.
Thomas V JestinLeads Clinical Research and Bio Services Pvt. Ltd, Bangalore, Karnataka, India.
Das S SyamAkay Natural Ingredients Private Limited, Kochi, Kerala, India.
Prabhakaran PrathibhaAkay Natural Ingredients Private Limited, Kochi, Kerala, India.
Nithyanandam AllimuthuTamil Nadu Government Multi Super Specialty Hospital, Chennai, Tamil Nadu, India.
N AbhiramiTranslational Nanomedicine and Lifestyle Disease Research Laboratory, Department of Biochemistry, University of Kerala, Thiruvananthapuram, Kerala, India.
A RadhikaDepartment of Biochemistry, Government Arts and Science College, Kulathoor, Thiruvananthapuram, Kerala, India.
I M KrishnakumarAkay Natural Ingredients Private Limited, Kochi, Kerala, India.
Janeesh Plakkal AyyappanTranslational Nanomedicine and Lifestyle Disease Research Laboratory, Department of Biochemistry, University of Kerala, Thiruvananthapuram, Kerala, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Non-restorative sleep is frequently associated with disturbances in circadian regulation, impaired sleep quality, and reduced daytime functioning. Methods: This randomized, double-blind, active-controlled, cross over study compared black cumin oil extract (TD; 200 mg) with synthetic melatonin (s-Mel; 5 mg/day) in 24 individuals with non-restorative sleep. Participants received each intervention for 7 nights separated by a 7-day washout period. Plasma melatonin was measured at fixed nighttime intervals under dim light to determine dim-light melatonin onset (DLMO), while sleep parameters were assessed using actigraphy. DLMO serves as an important physiological marker of circadian timing. Daytime sleepiness was evaluated with the Epworth Sleepiness Scale (ESS). Results: Both interventions significantly increased nocturnal plasma melatonin concentration under dim-light conditions ( Discussion: The interpretation of the corresponding threshold timing in the s-Mel arm was limited due to exogenous melatonin administration. s-Mel induced a rapid early rise in melatonin followed by a sharp decline, whereas TD demonstrated a more sustained nocturnal profile. Actigraphy outcomes were generally comparable; sleep latency and total sleep time improved more with s-Mel, while TD significantly reduced cortisol levels and daytime sleepiness. Overall, TD showed earlier threshold attainment, cortisol reduction, and improved daytime alertness, supporting its potential as a natural alternative for circadian disruption and non-restorative sleep. Clinical trial registration: https://ctri.nic.in/Clinicaltrials/pmaindet2.php?EncHid=MTExNTY4&Enc=&userName= CTRI/2024/11/077454 dated 28/11/2024.

Indexed as

circadian rhythmcortisoldim light melatonin onset (DLMO)melatoninNigella sativasleepstressthymoquinone

Identifiers

PMID42819242
PMCPMC13625438

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.